352 Final Results of the First in Man Trial of MK4827, a Poly (ADP-ribose) Polymerase (PARP) Inhibitor with Antitumor Activity in BRCA Carriers and Sporadic Cancer Patients
作者
Shahneen Kaur Sandhu,George Wilding,William R. Schelman,Aurelius Gabriel Omlin,N. Kreischer,C. Carpenter,R. Iannone,Stuart B. Kaye,Johann Sebastian De Bono,Robert M. Wenham